AstraZeneca PLC
AZN · NASDAQ
9/30/2025 | 6/30/2025 | 3/30/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $240 | $217 | $228 | $203 |
| - Cash | $8 | $7 | $5 | $5 |
| + Debt | $33 | $33 | $32 | $30 |
| Enterprise Value | $264 | $242 | $254 | $228 |
| Revenue | $15 | $14 | $14 | $15 |
| % Growth | 5.1% | 6.4% | -8.8% | – |
| Gross Profit | $12 | $12 | $11 | $12 |
| % Margin | 81.2% | 82.9% | 83.5% | 81.7% |
| EBITDA | $5 | $5 | $5 | $3 |
| % Margin | 33.8% | 34.3% | 37.1% | 18.9% |
| Net Income | $3 | $2 | $3 | $2 |
| % Margin | 16.7% | 16.9% | 21.5% | 10.1% |
| EPS Diluted | 0.81 | 0.79 | 0.94 | 0.48 |
| % Growth | 2.5% | -16% | 95.8% | – |
| Operating Cash Flow | $5 | $3 | $4 | $3 |
| Capital Expenditures | -$1 | -$2 | -$0 | -$1 |
| Free Cash Flow | $4 | $1 | $3 | $2 |